Open AccessKidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials
Author(s) -
Stefan D. Anker,
Piotr Ponikowski,
Christoph Wanner,
Egon Pfarr,
Sibylle J. Hauske,
Barbara Peil,
Afshin Salsali,
Ivana Ritter,
Audrey KoitkaWeber,
Martina Brueckmann,
JoAnn Lindenfeld,
William T. Abraham
Publication year - 2021
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.121.054669
Subject(s) - empagliflozin , medicine , discontinuation , heart failure , renal function , type 2 diabetes , diabetes mellitus , cardiology , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom